Takeda, Protagonist File NDA for Rusfertide in Polycythemia Vera
Takeda and Protagonist Therapeutics have submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval of rusfertide for the treatment of adults…
Read More...
Read More...
